Literature DB >> 8017544

An increase in Haemophilus influenzae type B vaccination among preschool-aged children in inner-city Los Angeles, 1990 through 1992.

D P Ewert1, S Westman, B Ward, N Bendaña, R Halbert, C M Vadheim, J I Ward, L Mascola.   

Abstract

Haemophilus influenzae type b (Hib) vaccination coverage and disease incidence were measured among preschool-aged children residing in inner-city Los Angeles. Among children 1.5 to 14 months of age, vaccination coverage of at least one dose increased from 0% in 1990 to 82% (95% confidence interval [CI] = 73%, 91%) in 1992. Among children 15 to 59 months old, vaccination coverage of at least one Hib dose administered at or after age 15 months increased from 35% (95% CI = 29%, 41%) in 1990 to 63% (95% CI = 56%, 70%) in 1992. Although Hib vaccination has reduced disease incidence in this population, greater use of vaccine can result in further reductions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017544      PMCID: PMC1614751          DOI: 10.2105/ajph.84.7.1154

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  10 in total

1.  Measles vaccination coverage among Latino children aged 12 to 59 months in Los Angeles County: a household survey.

Authors:  D P Ewert; J C Thomas; L Y Chun; R C Enguidanos; S H Waterman
Journal:  Am J Public Health       Date:  1991-08       Impact factor: 9.308

2.  Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method.

Authors:  R H Henderson; T Sundaresan
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

3.  Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.

Authors:  S B Black; H R Shinefield
Journal:  Pediatr Infect Dis J       Date:  1992-08       Impact factor: 2.129

4.  The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

Authors:  M Santosham; M Wolff; R Reid; M Hohenboken; M Bateman; J Goepp; M Cortese; D Sack; J Hill; W Newcomer
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

5.  Maternal recall error of child vaccination status in a developing nation.

Authors:  J J Valadez; L H Weld
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

6.  Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.

Authors:  A K Takala; J Eskola; M Leinonen; H Käyhty; A Nissinen; E Pekkanen; P H Mäkelä
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

7.  Decreases in invasive Haemophilus influenzae diseases in US Army children, 1984 through 1991.

Authors:  L E Broadhurst; R L Erickson; P W Kelley
Journal:  JAMA       Date:  1993-01-13       Impact factor: 56.272

8.  Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination.

Authors:  T V Murphy; K E White; P Pastor; L Gabriel; F Medley; D M Granoff; M T Osterholm
Journal:  JAMA       Date:  1993-01-13       Impact factor: 56.272

9.  Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.

Authors:  W G Adams; K A Deaver; S L Cochi; B D Plikaytis; E R Zell; C V Broome; J D Wenger
Journal:  JAMA       Date:  1993-01-13       Impact factor: 56.272

10.  Eradication of Haemophilus influenzae type b disease in southern California. Kaiser-UCLA Vaccine Study Group.

Authors:  C M Vadheim; D P Greenberg; E Eriksen; L Hemenway; N Bendana; L Mascola; J I Ward
Journal:  Arch Pediatr Adolesc Med       Date:  1994-01
  10 in total
  1 in total

1.  The children's agenda for the 1990s and beyond.

Authors:  S P Shelov
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.